text: Check it out, listen up, here's the scoop,
  NADH shuttles, they got some moves,
  Malate-aspartate shuttle, that's the MAS,
  Glycerol-3-phosphate shuttle, gonna pass.
  
  They transport those reducing equivalents,
  From cytosolic NADH, they're so efficient,
  Into mitochondria, that's the deal,
  Boosting energy production, it's real.
  
  But hold up, our study had a thought,
  In cancer cells, a function we sought,
  To maintain glycolysis, that's their game,
  By lowering NADH/NAD(+) ratios, no shame.
  
  We tested it out, AOAA in the mix,
  MAS inhibitor, causing a fix,
  ATP levels dropped, things got intense,
  Cell cycle messed up, apoptosis commenced.
  
  C6 glioma cells, they took the hit,
  Apoptosis and necrosis, that's legit,
  But primary astrocytes, they stayed strong,
  Surviving AOAA, they sang a different song.
  
  Glycolytic rate went down, that's the fact,
  Extracellular lactate and pyruvate lacked,
  Mitochondrial membrane potential, unaffected,
  AOAA's toxic effects, they got corrected.
  
  Pyruvate treatment, it saved the day,
  AOAA's harm, it kept at bay,
  So listen up, glioma cells beware,
  AOAA might getcha, it's a scare.
  
  MAS's major function, it's not the same,
  In cancer cells, it's got a different aim,
  Keeping glycolysis running, that's the key,
  Not boosting mitochondrial energy, you see.